Pharmaceutical Executive July 29, 2024
Mike Hollan

MGI Tech Co. issued a statement detailing the use of its technology in improving the rates of genomic sequencing in South Africa.

Genomic technology is being used in South Africa to research and identify natural controls for HIV infections. MGI Tech Co., announced its sequencing tools are being utilized at the South African Medical Research Council (SAMRC) and the University of KwaZulu-Natal. HIV continues to be a significant problem in the region, which has the largest number of people living with HIV.

However, MGI states that the African human genome is the least sequenced among human genomes. This presents a significant problem, as proper genetic sequencing allows experts to create more targeted treatment programs and create more effective treatments for...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine
Shifting the Paradigm in Whole-Genome Sequencing for Newborns

Share This Article